[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C][C][=C][C][=C][Branch1][Ring2][S][Ring1][Branch1][N][C][=Branch2][Ring1][Ring2][=N][N][=C][Ring1][Branch1][C][N][=C][Ring1][O][C][=C][C][=C][C][=C][Ring1][=Branch1][Cl][C]"}, {"from": "gpt", "value": "The molecule is easily oxidized, rapidly metabolized, and has a lower risk of accumulation, even after prolonged treatment. Etizolam has an anxiolytic action about 6 times greater than that of diazepam. Etizolam produces, especially at higher dosages, a reduction in time taken to fall asleep, an increase in total sleep time and a reduction in the number of awakenings. During tests there were not substantial changes in deep sleep. There is a reduction of REM sleep. In EEG tests of healthy volunteers Etizolam showed some characteristics of tricyclic antidepressants. Etizolam (marketed under the brand name Etilaam, Etizola, Sedekopan, Pasaden or Depas) is a thienodiazepine drug which is a benzodiazepine analog. The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring. It possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties."}]